How Part D plan sponsors miss opportunities for cost-saving interventions

drugs

Medicare Part D's medication therapy management component has the potential to improve care and cut costs, but giving plan sponsors too much liberty to decide eligibility requirements can hamper these efforts.

Part D prescription plans must offer medication therapy management, but since plan sponsors can set their own eligibility criteria, enrollment rates in medication therapy management averaged just 10 percent in 2012, according to a recently published Health Affairs study.

For some plan sponsors, just 0.2 percent of enrollees with multiple chronic conditions and high prescription expenditures were enrolled in medication therapy management. On the other end of the range, for some health plans as many as 57 percent of eligible enrollees were signed up for medication therapy management.

Digital Transformation

Unlock the Digital Front Door with an App

The Member Mobile App is the smarter and better way to engage members anytime and anywhere. Members can find the right doctors, receive alerts, track spending, use telehealth, and more — all within a guided, intuitive, and seamless experience. Built exclusively for payers, it is ready to install and launch in a few months. Request a consult on how to enable the digital front door with the Mobile App, today.

Such drastic variation creates inequities in access to medication therapy management, and results in missed opportunities for interventions that might improve healthcare outcomes and reduce spending, the researchers argue.

There is hope for improvement, however, in the Centers for Medicare & Medicaid Services' new Medicare Part D Enhanced Medication Therapy Management model, which is set to begin in 2017 and run for five years, the study notes.

The authors question, though, why Medicare Advantage Part D plans (MA-PDs) are not included in the new model, noting that compared with standalone prescription drug plans, "MA-PDs currently have greater financial incentives to ensure the success of medication therapy management interventions." 

Suggested Articles

Humana officials had to "rethink our role" with members when it came to responding to the COVID-19 pandemic.

CMS has rolled out a slew of policies aimed at offering greater flexibility amid COVID-19—but what changes are likely to stick around long-term?

Lawmakers want to make it easier for providers to get advance payment model bonuses next year when the requirements become harder.